[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tempus AI Cl A (TEM)

Tempus AI Cl A (TEM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,051,644
  • Shares Outstanding, K 180,435
  • Annual Sales, $ 1,272 M
  • Annual Income, $ -245,030 K
  • EBIT $ -283 M
  • EBITDA $ -176 M
  • 60-Month Beta 3.58
  • Price/Sales 7.00
  • Price/Cash Flow N/A
  • Price/Book 20.94

Options Overview Details

View History
  • Implied Volatility 72.51% (+12.69%)
  • Historical Volatility 95.52%
  • IV Percentile 43%
  • IV Rank 35.96%
  • IV High 95.11% on 10/10/25
  • IV Low 59.82% on 08/18/26
  • Expected Move (DTE 1) 3.26 (5.33%)
  • Put/Call Vol Ratio 0.12
  • Today's Volume 135,834
  • Volume Avg (30-Day) 23,151
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 332,128
  • Open Int (30-Day) 325,763
  • Expected Range 57.99 to 64.51

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $-0.30
  • Number of Estimates 5
  • High Estimate $-0.22
  • Low Estimate $-0.38
  • Prior Year $-0.31
  • Growth Rate Est. (year over year) +3.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
40.77 +50.23%
on 07/28/26
61.98 -1.18%
on 08/19/26
+8.78 (+16.73%)
since 07/17/26
3-Month
40.77 +50.23%
on 07/28/26
63.11 -2.95%
on 07/01/26
+15.72 (+34.53%)
since 05/19/26
52-Week
40.77 +50.23%
on 07/28/26
104.32 -41.29%
on 10/09/25
-11.83 (-16.19%)
since 08/19/25

Most Recent Stories

More News
CellCarta Adds Tempus to CDx Commercialization Lab Network

Tempus joins as a second commercial laboratory partnership to support oncology-focused access within CellCarta's CDx Accelerator Model.

TEM : 61.25 (+24.09%)
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications

Tempus' multimodal foundation model offers diagnostic-grade precision for cancer detection and unlocks broader applications predicting biomarker status and patient prognosis

TEM : 61.25 (+24.09%)
Tempus: Q2 Earnings Snapshot

Tempus: Q2 Earnings Snapshot

TEM : 61.25 (+24.09%)
Tempus Reports Second Quarter 2026 Results

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today reported financial results for the quarter ended June 30, 2026. “Q2 was another...

TEM : 61.25 (+24.09%)
Dear Tempus AI Stock Fans, Mark Your Calendars for July 30

Tempus AI is set to report its Q2 results today. Investors will be watching.

PSNL : 15.81 (+13.66%)
TEM : 61.25 (+24.09%)
Tempus AI Has Set Itself Up for Another Consensus-Beating Quarter

Barchart Research What to Expect from TEM Earnings TEM Generated July 29, 2026 Current Price $41.55 EPS Estimate $$-0.41 Consensus Rating Moderate Buy Average Move 6.67% Tempus AI Has Set Itself Up for...

TEM : 61.25 (+24.09%)
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the national launch of its OneOme pharmacogenomics (PGx) testing...

TEM : 61.25 (+24.09%)
Personalis Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Personalis, Inc. - PSNL

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Personalis ,...

PSNL : 15.81 (+13.66%)
TEM : 61.25 (+24.09%)
Tempus AI to Acquire Personalis in $1.5 Billion Deal to Expand Precision Oncology Platform

Tempus AI ($TEM) has agreed to acquire Personalis ($PSNL) in an all-stock transaction valued at approximately $1.5 billion in enterprise value, expanding its capabilities in minimal residual disease (MRD)...

PSNL : 15.81 (+13.66%)
TEM : 61.25 (+24.09%)
Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

Acquisition brings together Personalis’ MRD technology with Tempus’ commercial scale, multimodal data and AI platform to advance cancer monitoring, deepen insights and accelerate growth ...

PSNL : 15.81 (+13.66%)
TEM : 61.25 (+24.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Average short term outlook on maintaining the current direction.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery,...

See More

Key Turning Points

3rd Resistance Point 71.05
2nd Resistance Point 66.52
1st Resistance Point 63.88
Last Price 61.25
1st Support Level 56.71
2nd Support Level 52.18
3rd Support Level 49.54

See More

52-Week High 104.32
Fibonacci 61.8% 80.04
Fibonacci 50% 72.54
Fibonacci 38.2% 65.05
Last Price 61.25
52-Week Low 40.77

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.